Utilization of Microarrayed Compound Screening (μARCS) to Identify Inhibitors of p56lck Tyrosine Kinase

Abstract

Protein tyrosine kinases play critical roles in cell signaling and are considered attractive targets for drug discovery. The authors have applied μARCS (microarrayed compound screening) technology to develop a high-throughput screen for finding inhibitors of the p56^lck tyrosine kinase. Initial assay development was performed in a homogeneous time-resolved (LANCE™) format in 96-well microplates and then converted into the gel-based μARCS format. The μARCS methodology is a well-less screening format in which 8640 compounds are arrayed on a microplate-sized piece of polystyene and subsequently assayed by placing reagents cast in agarose gels in contact with these compound sheets. A blotting paper soaked with adenosine triphosphate is applied on the gel to initiate the kinase reaction in the gel. Using this screening methodology, 300,000 compounds were screened in less than 40 h. Substantial reagent reduction was achieved by converting this tyrosine kinase assay from a 96-well plate assay to μARCS, resulting in significant cost savings. (Journal of Biomolecular Screening 2004: 12-21)

References

1. Blume-Jensen P, Hunter T: Oncogenic kinase signaling . Nature 2001;411: 355-365 .

2. Traxler P, Bold G, Buchdunger E, Caravatti G, Furet P, Manly P, et al: Tyrosine kinase inhibitors: from rational designs to clinical trials . Med Res Rev 2001;21(6): 499-512 .

3. Fabbro D: Protein tyrosine kinase inhibitors: new treatment modalities . Curr Opin Pharmacol 2002;2: 374-381 .

4. Druker BJ, Talpaz M, Resta DJ, et al: Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia . N Engl J Med 2001;344: 1031-1037 .

5. Weiss A, Littman DR: Signal transduction by lymphocyte antigen receptors . Cell 1994;76: 263-274 .

6. Chan AC, Desai DM, Weiss A: The role of protein tyrosine kinases and protein tyrosine phosphatases in T cell antigen receptor signal transduction . Annu Rev Immunol 1994;12: 555-592 .

7. Straus D, Weiss A: Genetic evidence for the involvement of the lck tyrosine kinase in signal transduction through the T cell antigen receptor . Cell 1992;70: 585 .

8. Beutel BA, Schurdak ME, Voorbach MJ, Burns DJ, Joseph MK: Continuous format high throughput screening. U.S. Patent 5,976,813, 1999.

9. Burns DJ, Kofron JL, Warrior U, Beutel BA: Well-less, gel-permeation formats for ultra-HTS . Drug Discov Today 2001;6(12): S40-S47 .

10.

10. Schurdak, ME, Voorbach MJ, Gao L, et al: Complex gel permeation assays for screening combinatorial libraries . J Biomol Screen 2001;6(5): 313-322 .

11.

11. Gopalakrishnan SM, Karvinen J, Kofron JL, Burns DJ, Warrior U: Application of micro arrayed compound screening (microARCS) to identify inhibitors of caspase-3 .J Biomol Screen 2002;7(4): 317-323 .

12.

12. David CA, Middleton T, Montgomery D, et al: Microarray compound screening (microARCS) to identify inhibitors of HIV integrase . J Biomol Screen 2002;7(3): 259-266 .

13.

13. Biazzo-Ashnault DE, Park Y-W, Cummings RT, et al: Detection of insulin receptor tyrosine kinase activity using time-resolved fluorescence energy transfer technology . Anal Biochem 2001;291: 155-158 .

14.

14. Zhang J-H, Chung TDY, Oldenburg KR: A simple statistical parameter for use in evaluation and validation of high throughput screening . JBiomol Screen 1999;4: 67-73 .

15.

15. Voorbach M, Wakat J, Kidonakis I, et al: Custom software for use in continuous format high throughput screening [Poster 106] . Paper presented at the 5th Annual Society for Biomolecular Screening Conference and Exhibition, Edinburgh, UK, September 13-16, 1999.